Mesothelin-targeted MRI for assessing migration, invasion, and prognosis in malignant pleural mesothelioma

被引:1
作者
Huang, Yilong [1 ]
Shen, Shasha [1 ]
Xiao, Jie [2 ]
Luo, Cici [3 ]
Ma, Jiyao [1 ]
Huang, Xin [3 ]
Qi, Tianfu [1 ]
Gao, Chao [1 ]
Li, Guiyun [4 ]
Li, Fan [5 ]
He, Bo [1 ]
Chen, Bingdi [3 ]
Han, Dan [1 ]
机构
[1] Kunming Med Univ, Dept Med Imaging, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China
[2] Hubei Polytech Univ, Huangshi Cent Hosp, Dept Pathol, Affiliated Hosp, Huangshi, Hubei, Peoples R China
[3] Tongji Univ, Inst Biomed Engn & Nano Sci, Sch Med, 67,Chifeng Rd,Yangpu Dist, Shanghai 200092, Peoples R China
[4] Kunming Med Univ, Dept Pathol, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
[5] Kunming Med Univ, Sch Basic Med Sci, Dept Pathol & Pathophysiol, Kunming, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
Nanoprobe; Targeted imaging; Malignant pleural mesothelioma; Mesothelin; Prognosis; SERUM MESOTHELIN; ENVIRONMENTAL EXPOSURE; IN-VITRO; CANCER; OVEREXPRESSION; SURVIVAL; ADHESION;
D O I
10.1186/s12645-023-00238-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMesothelin (MSLN) has been implicated in cancer migration, invasion, and prognosis, making it a potential tumor marker. However, the precise role of MSLN in the migration and invasion of malignant pleural mesothelioma (MPM) remains elusive, and effective noninvasive methods for assessing MSLN status are currently lacking. In this study, we focused on MSLN expression and elucidated the underlying mechanisms by which MSLN regulates migration and invasion in MPM. Building upon this knowledge, we developed an MRI nanoprobe that targets MSLN to assess its status in vitro and in vivo by comparing T2 signal intensity and T2 values on magnetic resonance imaging examinations. This nanoprobe combines the anatomical information obtained from MRI with biological information obtained from MSLN for comprehensive evaluation of MPM.ResultsNotably, we observed that MSLN expression in the epithelial type of MPM was higher and increased continuously with tumor growth than that in other types. In addition, MSLN upregulation promoted N-cadherin, matrix metalloproteinase-7, and MMP9 expression and resulted in higher migration/invasion ability and shorter survival. We synthesized MSLN-targeted nanoprobes (Fe3O4@SiO2-PEG-MSLN, FSPM) to assess MSLN expression by comparing the T2 signal intensity and T2 value of different cell lines and mice after 14, 28, and 42 days of modeling. Remarkably, MSLN-targeted nanoprobes demonstrated excellent targeting capabilities. In vitro studies revealed a pronounced reduction in T2 signal intensity and T2 values of the epithelial type as the probe concentration increased. In addition, in vivo experiments demonstrated a gradual decline in these parameters over time, particularly in the epithelial type as compared to the biphasic type, corresponding to the dynamic expression patterns of MSLN during different growth stages.ConclusionOur comprehensive research succeeded in confirming the regulatory mechanisms by which MSLN influences migration and invasion. Moreover, we introduced a promising method for monitoring MSLN expression that may help in facilitating the early detection, histological subtype identification, and assessment of migration, invasion, and prognosis in MPM.
引用
收藏
页数:21
相关论文
共 47 条
  • [1] Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration
    An, Zhengwen
    Dobra, Katalin
    Lock, John G.
    Stromblad, Staffan
    Hjerpe, Anders
    Zhang, Hongquan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (09) : 1999 - 2008
  • [2] Superparamagnetic iron oxides as MPI tracers: A primer and review of early applications
    Bulte, Jeff W. M.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2019, 138 : 293 - 301
  • [3] Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
    Chang, Ming-Cheng
    Chen, Chi-An
    Chen, Pao-Jen
    Chiang, Ying-Cheng
    Chen, Yu-Li
    Mao, Tsui-Lien
    Lin, Han-Wei
    Chiang, Wen-Hsien Lin
    Cheng, Wen-Fang
    [J]. BIOCHEMICAL JOURNAL, 2012, 442 : 293 - 302
  • [4] Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
    Chen, Shih-Hsun
    Hung, Wei-Chien
    Wang, Pu
    Paul, Colin
    Konstantopoulos, Konstantinos
    [J]. SCIENTIFIC REPORTS, 2013, 3
  • [5] THE PATHOGENESIS OF ASBESTOS-ASSOCIATED DISEASES
    CRAIGHEAD, JE
    MOSSMAN, BT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (24) : 1446 - 1455
  • [6] Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma
    Cristaudo, Alfonso
    Bonotti, Alessandra
    Simonini, Silvia
    Vivaldi, Agnese
    Guglielmi, Giovanni
    Ambrosino, Nicolino
    Chella, Antonio
    Lucchi, Marco
    Mussi, Alfredo
    Foddis, Rudy
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1587 - 1593
  • [7] A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma
    de Fonseka, Duneesha
    Arnold, David T.
    Stadon, Louise
    Morley, Anna
    Keenan, Emma
    Darby, Michael
    Armstrong, Lynne
    Virgo, Paul
    Maskell, Nick A.
    [J]. BMC CANCER, 2018, 18
  • [8] Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer
    Gao, Peng
    Mei, Chaoming
    He, Lizhen
    Xiao, Zeyu
    Chan, Leung
    Zhang, Dong
    Shi, Changzheng
    Chen, Tianfeng
    Luo, Liangping
    [J]. DRUG DELIVERY, 2018, 25 (01) : 1811 - 1825
  • [9] Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model
    Ghosh, Subrata K.
    Uchida, Masashi
    Yoo, Byunghee
    Ross, Alana W.
    Gendler, Sandra J.
    Gong, Jianlin
    Moore, Anna
    Medarova, Zdravka
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (08) : 1860 - 1867
  • [10] Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy
    Hanaoka, Tatsuya
    Hasegawa, Kosei
    Kato, Tomomi
    Sato, Sho
    Kurosaki, Akira
    Miyara, Akiko
    Nagao, Shoji
    Seki, Hiroyuki
    Yasuda, Masanori
    Fujiwara, Keiichi
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (02) : 187 - 198